• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型抗癌策略二。

Novel Anticancer Strategies II.

作者信息

Bousbaa Hassan

机构信息

UNIPRO-Oral Pathology and Rehabilitation Research Unit, Institute of Health Sciences (IUCS), Cooperativa de Ensino Superior Politécnico e Universitário (CESPU), Rua Central de Gandra 1317, 4585-116 Gandra, Portugal.

Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR), Universidade do Porto, Terminal de Cruzeiros do Porto de Leixões, Av. General Norton de Matos s/n, 4450-208 Matosinhos, Portugal.

出版信息

Pharmaceutics. 2023 Feb 10;15(2):605. doi: 10.3390/pharmaceutics15020605.

DOI:10.3390/pharmaceutics15020605
PMID:36839927
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9959780/
Abstract

Owing to the exceptional complexity of the development and progression of cancer, diverse cancer types are alarmingly increasing worldwide [...].

摘要

由于癌症发生和发展的异常复杂性,全球范围内各种癌症类型的数量正以惊人的速度增长[...]。

相似文献

1
Novel Anticancer Strategies II.新型抗癌策略二。
Pharmaceutics. 2023 Feb 10;15(2):605. doi: 10.3390/pharmaceutics15020605.
2
Mangrove-Associated Fungi: A Novel Source of Potential Anticancer Compounds.红树林相关真菌:潜在抗癌化合物的新来源。
J Fungi (Basel). 2018 Aug 24;4(3):101. doi: 10.3390/jof4030101.
3
Molecular Profiling of Exceptional Responders to Cancer Therapy.癌症治疗中极具疗效反应者的分子剖析。
Oncologist. 2021 Mar;26(3):186-195. doi: 10.1002/onco.13600. Epub 2020 Nov 28.
4
Recent Developments of Target Based Coumarin Derivatives as Potential Anticancer Agents.基于香豆素衍生物的新型抗癌药物的研究进展。
Mini Rev Med Chem. 2020;20(17):1754-1766. doi: 10.2174/1389557520666200510000718.
5
Exosomal delivery of TRAIL and miR‑335 for the treatment of hepatocellular carcinoma (Review).外泌体递送 TRAIL 和 miR-335 用于治疗肝细胞癌 (综述)。
Int J Mol Med. 2023 Jan;51(1). doi: 10.3892/ijmm.2022.5206. Epub 2022 Nov 23.
6
A Review of the Components of Seaweeds as Potential Candidates in Cancer Therapy.海藻成分作为癌症治疗潜在候选物的综述。
Anticancer Agents Med Chem. 2018;18(3):354-366. doi: 10.2174/1871520617666171106130325.
7
Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.血管紧张素转换酶抑制剂与血管紧张素II受体阻滞剂联合治疗以阻止慢性肾病进展:病理生理学与适应证
Kidney Int. 2005 Mar;67(3):799-812. doi: 10.1111/j.1523-1755.2005.00145.x.
8
The Antimalarial Drug Pyronaridine Inhibits Topoisomerase II in Breast Cancer Cells and Hinders Tumor Progression .抗疟药物咯萘啶抑制乳腺癌细胞中的拓扑异构酶II并阻碍肿瘤进展。
Clin Cancer Drugs. 2021 Mar;8(1):50-56. doi: 10.2174/2212697x08666210219101023. Epub 2021 Feb 19.
9
A comprehensive review of exceptional responders to anticancer drugs in the biomedical literature.抗癌药物生物医学文献中罕见应答者的全面综述。
Eur J Cancer. 2018 Sep;101:143-151. doi: 10.1016/j.ejca.2018.06.010. Epub 2018 Jul 27.
10
Advances in chalcones with anticancer activities.具有抗癌活性的查耳酮类化合物的研究进展。
Recent Pat Anticancer Drug Discov. 2015;10(1):97-115. doi: 10.2174/1574892809666140819153902.

引用本文的文献

1
Cutting-Edge Advances in Anticancer Therapies: Insights from the Third Edition of the Special Issue "Novel Anticancer Strategies".抗癌疗法的前沿进展:来自特刊《新型抗癌策略》第三版的见解
Pharmaceutics. 2025 Jan 3;17(1):54. doi: 10.3390/pharmaceutics17010054.

本文引用的文献

1
Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs.寡核苷酸疗法在针对不可成药蛋白和非编码RNA的临床研究中的精准抗癌药物
Pharmaceutics. 2022 Jul 12;14(7):1453. doi: 10.3390/pharmaceutics14071453.
2
PD-1 Cellular Nanovesicles Carrying Gemcitabine to Inhibit the Proliferation of Triple Negative Breast Cancer Cell.携带吉西他滨的程序性死亡受体1细胞纳米囊泡抑制三阴性乳腺癌细胞的增殖
Pharmaceutics. 2022 Jun 14;14(6):1263. doi: 10.3390/pharmaceutics14061263.
3
Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems.纳维托克司增强了PLK1靶向治疗在二维和三维培养系统中对肺癌细胞的治疗效果。
Pharmaceutics. 2022 Jun 6;14(6):1209. doi: 10.3390/pharmaceutics14061209.
4
HPMA Copolymer Mebendazole Conjugate Allows Systemic Administration and Possesses Antitumour Activity In Vivo.HPMA共聚物美苯达唑偶联物可实现全身给药并在体内具有抗肿瘤活性。
Pharmaceutics. 2022 Jun 4;14(6):1201. doi: 10.3390/pharmaceutics14061201.
5
Evaluation of 3-Borono-l-Phenylalanine as a Water-Soluble Boron Neutron Capture Therapy Agent.3-硼-1-苯丙氨酸作为水溶性硼中子俘获治疗剂的评估
Pharmaceutics. 2022 May 22;14(5):1106. doi: 10.3390/pharmaceutics14051106.
6
BUB3, beyond the Simple Role of Partner.BUB3,超越伴侣的简单角色。
Pharmaceutics. 2022 May 18;14(5):1084. doi: 10.3390/pharmaceutics14051084.
7
Persistent Properties of a Subpopulation of Cancer Cells Overexpressing the Hedgehog Receptor Patched.过表达刺猬信号通路受体Patched的癌细胞亚群的持续特性
Pharmaceutics. 2022 May 5;14(5):988. doi: 10.3390/pharmaceutics14050988.
8
Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers.靶向新抗原以诱导针对癌症的T细胞免疫的治疗性疫苗。
Pharmaceutics. 2022 Apr 15;14(4):867. doi: 10.3390/pharmaceutics14040867.
9
CHRNA5 Contributes to Hepatocellular Carcinoma Progression by Regulating YAP Activity.CHRNA5通过调节YAP活性促进肝细胞癌进展。
Pharmaceutics. 2022 Jan 25;14(2):275. doi: 10.3390/pharmaceutics14020275.
10
Current Status of the Use of Multifunctional Enzymes as Anti-Cancer Drug Targets.多功能酶作为抗癌药物靶点的应用现状
Pharmaceutics. 2021 Dec 21;14(1):10. doi: 10.3390/pharmaceutics14010010.